Tag: Viking Therapeutics

The biotech sector's attention is firmly fixed on Viking Therapeutics as the company prepares for a featured presentation at the ...

Viking Therapeutics has captured significant market attention following the release of impressive clinical trial results for its obesity treatment candidate ...

Viking Therapeutics is generating significant attention in the biotech sector with new clinical findings for its experimental weight-loss treatment, VK2735. ...

Investors in Viking Therapeutics were met with sobering financial results for the third quarter of 2025, as the biotechnology firm ...

Viking Therapeutics is experiencing significant positive momentum this October, driven by substantial progress in its obesity treatment candidate VK2735. The ...

Viking Therapeutics stands at a pivotal moment in its corporate trajectory. The biotechnology firm has initiated a new maintenance study ...

Shares of Viking Therapeutics are experiencing significant price swings as investors position themselves ahead of the company's October 22 quarterly ...

Viking Therapeutics is experiencing the downside of its ambitious growth strategy. Recent clinical developments have tempered investor enthusiasm for the ...

Viking Therapeutics shares continue to face significant downward momentum amid persistent selling activity. Despite the company's advanced clinical development programs, ...

The biotechnology sector is currently experiencing unprecedented merger and acquisition activity, with Viking Therapeutics emerging as a potential target in ...